[제약사 리포트] 파마리서치, 1Q 리쥬란 기대이하…화장품發 이익 방어

PharmaResearch's 1Q results demonstrate a strategic pivot where high-growth cosmetics successfully cushioned the temporary slowdown in Rejuran medical device sales. The expansion into global channels like Sephora and SiliconTwo highlights the company's evolving resilience against seasonal medical tourism fluctuations. This shift signifies PharmaResearch's transition from a domestic medical device specialist to a diversified global beauty player.